Connect with us

Business

Pfizer Says FDA Will Soon Authorize COVID-19 Vaccine For 12-15 Age Group – NPR

The company said in late March that clinical trials showed the vaccine elicits “100% efficacy and robust antibody responses” in adolescents.

Published

on

Article feature image
ADVERTISEMENT

Syringes filled with the Pfizer-BioNTech COVID-19 vaccine are shown in April at the Christine E. Lynn Rehabilitation Center in Miami.
Wilfredo Lee/AP
The U.S. Food and Drug Administration is expected to authorize the Pfizer-BioNTech COVID-19 vaccine for children 12 to 15 years old, a decision that could come by some time early next week. The vaccine is currently authorized only for people age 16 and older.
A ruling should come “shortly,” Pfizer Chairman and CEO Albert Bourla told investors in a…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Payment tech company Marqeta files for IPO as value tops $16 billion on private markets – CNBC
Article feature image
Costco, one of the first to require masks, drops face-covering requirement for fully vaccinated at some clubs – USA TODAY
Article feature image
A bitcoin battle of the billionaires ensues as Jack Dorsey faces off with Musk on ‘green’ merits of world’s No. 1 crypto – MarketWatch